Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Int. braz. j. urol ; 45(2): 299-305, Mar.-Apr. 2019. tab
Article in English | LILACS | ID: biblio-1002199

ABSTRACT

ABSTRACT Purpose: To describe the clinical characteristics, treatment patterns, and outcomes in patients with small cell bladder cancer at our institution, including those who received prophylactic cranial irradiation (PCI) for the prevention of intracranial recurrence. Materials and Methods: Patients with small cell bladder cancer treated at a single institution between January 1990 and August 2015 were identified and analyzed retrospectively for demographics, tumor stage, treatment, and overall survival. Results: Of 44 patients diagnosed with small cell bladder cancer, 11 (25%) had metastatic disease at the time of presentation. Treatment included systemic chemotherapy (70%), radical surgery (59%), and local radiation (39%). Six patients (14%) received PCI. Median overall survival was 10 months (IQR 4 - 41). Patients with extensive disease had worse overall survival than those with organ confined disease (8 months vs. 36 months, respectively, p = 0.04). Among those who received PCI, 33% achieved 5 - year survival. Conclusion: Outcomes for patients with small cell bladder cancer remain poor. Further research is indicated to determine if PCI increases overall survival in small call bladder cancer patients, especially those with extensive disease who respond to chemotherapy.


Subject(s)
Humans , Male , Aged , Aged, 80 and over , Urinary Bladder Neoplasms/radiotherapy , Cranial Irradiation/methods , Carcinoma, Small Cell/radiotherapy , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/pathology , Survival Analysis , Retrospective Studies , Carcinoma, Small Cell/mortality , Carcinoma, Small Cell/pathology , Small Cell Lung Carcinoma/pathology , Small Cell Lung Carcinoma/radiotherapy , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Lung Neoplasms/radiotherapy
2.
J Surg Oncol ; 113(2): 218-22, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26775909

ABSTRACT

BACKGROUND AND OBJECTIVES: To evaluate whether urologic procedures during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) are associated with adverse postoperative outcomes. METHODS: We identified patients who underwent CRS-HIPEC at our institution from 2001 to 2012 and compared outcomes between operations that did and did not include a urologic procedure. RESULTS: A total of 938 CRS-HIPEC procedures were performed, 71 of which included a urologic intervention. Urologic interventions were associated with longer operative times (547 vs. 459 min, P < 0.001) and greater length of stay (15 vs. 12 days, P = 0.003). Major complications (Clavien III and IV) were more common in the urologic group (31% vs. 20%, P = 0.028). On multivariable analysis, urologic procedures were associated with a low anterior resection (OR: 2.25, 95%CI 1.07-4.74, P = 0.033) and a greater number of enteric anastomoses (OR: 1.83, 95%CI 1.31-2.56, P < 0.001). At a median follow up of 17 months (IQR 5.6-35 months), addition of a urologic procedure did not significantly impact overall survival for appendiceal or colorectal cancers. CONCLUSION: Urologic surgery at the time of CRS-HIPEC is associated with longer operative times, length of stay and increased risk of major complications, but not with decreased overall survival. J. Surg. Oncol. 2016;113:218-222. © 2016 Wiley Periodicals, Inc.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Appendiceal Neoplasms/therapy , Chemotherapy, Cancer, Regional Perfusion/methods , Colorectal Neoplasms/therapy , Cytoreduction Surgical Procedures , Hyperthermia, Induced , Peritoneal Neoplasms/therapy , Urologic Surgical Procedures/adverse effects , Adult , Aged , Appendiceal Neoplasms/mortality , Appendiceal Neoplasms/pathology , Appendiceal Neoplasms/surgery , Chemotherapy, Adjuvant/methods , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Female , Humans , Kaplan-Meier Estimate , Length of Stay , Male , Middle Aged , Odds Ratio , Operative Time , Peritoneal Neoplasms/mortality , Peritoneal Neoplasms/secondary , Peritoneal Neoplasms/surgery , Retrospective Studies , Treatment Outcome
3.
Can J Urol ; 20(2): 6737-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23587517

ABSTRACT

A 10-year-old boy underwent a computed tomography (CT) scan for left flank pain following a fall. Imaging demonstrated a 5 cm left upper pole renal mass. Partial nephrectomy revealed metanephric adenofibroma, a benign stromal-epithelial tumor thought to represent a hyperdifferentiated, mature form of Wilms' tumor. We briefly discuss the histopathology and management of this rare tumor.


Subject(s)
Adenofibroma/diagnosis , Disease Management , Kidney Neoplasms/diagnosis , Nephrectomy , Adenofibroma/pathology , Adenofibroma/surgery , Child , Diagnosis, Differential , Humans , Kidney/diagnostic imaging , Kidney/pathology , Kidney/surgery , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Male , Tomography, X-Ray Computed , Treatment Outcome , Wilms Tumor/diagnosis , Wilms Tumor/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...